{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:10:21Z","timestamp":1769875821197,"version":"3.49.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,15]]},"DOI":"10.1097\/01.tp.0000296856.53493.1f","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T06:06:08Z","timestamp":1236233168000},"page":"102-111","source":"Crossref","is-referenced-by-count":13,"title":["A Second Prophylactic MHC-Mismatched Bone Marrow Transplantation Protects Against Rat Acute Myeloid Leukemia (BNML) Without Lethal Graft-Versus-Host Disease"],"prefix":"10.1097","volume":"85","author":[{"given":"Janne M.","family":"Nestvold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente K.","family":"Omdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Zheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Martens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haakon B.","family":"Benestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Vaage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bent","family":"Rolstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V96.12.3948","article-title":"Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia.","volume":"96","author":"Venditti","year":"2000","journal-title":"Blood"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/35077251","article-title":"Haematopoietic cell transplantation as immunotherapy.","volume":"411","author":"Appelbaum","year":"2001","journal-title":"Nature"},{"key":"R3-17-20210129","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation.","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation (second of two parts).","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease.","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","article-title":"Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.","volume":"29","author":"Anasetti","year":"1990","journal-title":"Hum Immunol"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase ii study in patients with acute leukemia at high risk of relapse.","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/sj.leu.2404334","article-title":"Stem cell transplantation with reduced-intensity conditioning regimens: A review of ten years experience with new transplant concepts and new therapeutic agents.","volume":"20","author":"Barrett","year":"2006","journal-title":"Leukemia"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminoncol.2003.10.016","article-title":"Nonmyeloablative stem cell transplantation: Reduced-intensity conditioning for cancer immunotherapy\u2013from bench to patient bedside.","volume":"31","author":"Slavin","year":"2004","journal-title":"Semin Oncol"},{"key":"R10-17-20210129","first-page":"18","article-title":"Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.","volume":"111","author":"Champlin","year":"2000","journal-title":"Br J Haematol"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1083-8791(03)00077-6","article-title":"Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.","volume":"9","author":"Dey","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"R13-17-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bmt.1703779","article-title":"Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study.","volume":"31","author":"Lewalle","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3324\/haematol.10570","article-title":"Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched\/haploidentical T-cell-replete hematopoietic stem cell transplantation.","volume":"92","author":"Huang","year":"2007","journal-title":"Haematologica"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-065X.2001.1810112.x","article-title":"Rat natural killer cell receptor systems and recognition of MHC class I molecules.","volume":"181","author":"Rolstad","year":"2001","journal-title":"Immunol Rev"},{"key":"R16-17-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition.","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/sj.leu.2403524","article-title":"Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation.","volume":"18","author":"Passweg","year":"2004","journal-title":"Leukemia"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bcmd.2004.08.013","article-title":"IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.","volume":"33","author":"Koehl","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-3083.2001.00929.x","article-title":"Long-term donor chimerism after MHC (RT1) mismatched bone marrow transplantation in the rat: The role of host alloreactive NK cells.","volume":"54","author":"Engh","year":"2001","journal-title":"Scand J Immunol"},{"key":"R20-17-20210129","first-page":"667","article-title":"Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.","volume":"12","author":"Martens","year":"1984","journal-title":"Exp Hematol"},{"key":"R21-17-20210129","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2402550","article-title":"Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.","volume":"16","author":"Perez-Simon","year":"2002","journal-title":"Leukemia"},{"key":"R22-17-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/002367794781065933","article-title":"Recommendations for the health monitoring of mouse, rat, hamster, guineapig and rabbit breeding colonies. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management November 1992.","volume":"28","year":"1994","journal-title":"Lab Anim"},{"key":"R23-17-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2403670","article-title":"Animal models of acute myelogenous leukaemia: Development, application and future perspectives.","volume":"19","author":"McCormack","year":"2005","journal-title":"Leukemia"},{"key":"R24-17-20210129","first-page":"241","article-title":"The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).","volume":"4","author":"Martens","year":"1990","journal-title":"Leukemia"},{"key":"R25-17-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-3083.1990.tb02821.x","article-title":"RT7-defined alloantigens in rats are part of the leucocyte common antigen family.","volume":"31","author":"Kampinga","year":"1990","journal-title":"Scand J Immunol"},{"key":"R26-17-20210129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.162.2.743","article-title":"RT1-U: Identification of a novel, active, class Ib alloantigen of the rat MHC.","volume":"162","author":"Leong","year":"1999","journal-title":"J Immunol"},{"key":"R27-17-20210129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1196\/annals.1349.010","article-title":"Hematopoietic stem cell transplantation across major genetic barriers: Tolerance induction by megadose CD34 cells and other veto cells.","volume":"1044","author":"Reisner","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"R28-17-20210129","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice.","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat Med"},{"key":"R29-17-20210129","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"R30-17-20210129","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/10428190500264496","article-title":"Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation.","volume":"46","author":"Schulenburg","year":"2005","journal-title":"Leukemia Lymphoma"},{"key":"R31-17-20210129","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/eji.1830250518","article-title":"Alloreactive natural killer cells in the rat: complex genetics of MHC control.","volume":"25","author":"Naper","year":"1995","journal-title":"Eur J Immuol"},{"key":"R32-17-20210129","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood-2004-08-3213","article-title":"Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.","volume":"105","author":"Hanash","year":"2005","journal-title":"Blood"},{"key":"R33-17-20210129","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses.","volume":"94","author":"Childs","year":"1999","journal-title":"Blood"},{"key":"R34-17-20210129","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.exphem.2005.05.001","article-title":"Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.","volume":"33","author":"Meignin","year":"2005","journal-title":"Exp Hematol"},{"key":"R35-17-20210129","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"key":"R36-17-20210129","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.20011603","article-title":"Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.","volume":"195","author":"Gilliet","year":"2002","journal-title":"J Exp Med"},{"key":"R37-17-20210129","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.4049\/jimmunol.178.10.6242","article-title":"Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.","volume":"178","author":"Pillai","year":"2007","journal-title":"J Immunol"},{"key":"R38-17-20210129","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.189.7.1073","article-title":"Bone marrow NK1.1- and NK1.1+ T cells reciprocally regulate acute graft versus host disease.","volume":"189","author":"Zeng","year":"1999","journal-title":"J Exp Med"},{"key":"R39-17-20210129","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect.","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"key":"R40-17-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0145-2126(80)90086-7","article-title":"F1 Hybrid resistance to bn rat myelogenous leukemia parallels resistance to transplantation of normal bn bone marrow.","volume":"4","author":"Williams","year":"1980","journal-title":"Leukemia Res"},{"key":"R41-17-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-1759(94)00270-7","article-title":"Recruitment of alloreactive natural killer cells to the rat peritoneum by a transfected cell line secreting rat recombinant interleukin-2.","volume":"179","author":"L\u00f8vik","year":"1995","journal-title":"J Immunol Meth"},{"key":"R42-17-20210129","first-page":"86","article-title":"Spontaneous alloreactivity of natural killer (NK) and lymphokine- activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.","volume":"74","author":"Rolstad","year":"1991","journal-title":"Immunology"},{"key":"R43-17-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1074-7613(01)00122-4","article-title":"Mixed chimerism and transplant tolerance.","volume":"14","author":"Sykes","year":"2001","journal-title":"Immunity"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200801150-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:01:05Z","timestamp":1710126065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200801150-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000296856.53493.1f","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}